Name
As of 12/20/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
5.7%
1 yr return
9.6%
3 Yr Avg Return
1.4%
5 Yr Avg Return
5.7%
Net Assets
$1.78 B
Holdings in Top 10
65.5%
52 WEEK LOW AND HIGH
$22.5
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 1.71%
SALES FEES
Front Load N/A
Deferred Load 1.00%
TRADING FEES
Turnover 72.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
$500
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 12/20/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
FBTCX - Profile
Distributions
- YTD Total Return 5.7%
- 3 Yr Annualized Total Return 1.4%
- 5 Yr Annualized Total Return 5.7%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio -0.55%
- Dividend Yield 0.0%
- Dividend Distribution Frequency None
Fund Details
-
Legal NameFidelity Advisor Biotechnology Fund
-
Fund Family NameFidelity Investments
-
Inception DateJan 12, 2001
-
Shares OutstandingN/A
-
Share ClassC
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerEirene Kontopoulos
Fund Description
Normally investing primarily in common stocks. Normally investing at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Read More
FBTCX - Performance
Return Ranking - Trailing
| Period | FBTCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 5.7% | -27.8% | 19.0% | 25.16% |
| 1 Yr | 9.6% | -27.8% | 18.5% | 20.13% |
| 3 Yr | 1.4%* | -28.3% | 7.9% | 23.03% |
| 5 Yr | 5.7%* | -11.6% | 11.4% | 42.95% |
| 10 Yr | 5.6%* | -0.5% | 12.6% | 69.91% |
* Annualized
Return Ranking - Calendar
| Period | FBTCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 9.9% | -12.6% | 19.0% | 10.69% |
| 2022 | -8.6% | -53.9% | 3.2% | 23.68% |
| 2021 | -23.3% | -39.6% | 24.2% | 90.79% |
| 2020 | 19.6% | -13.6% | 178.2% | 30.87% |
| 2019 | 15.6% | 3.8% | 63.8% | 78.95% |
Total Return Ranking - Trailing
| Period | FBTCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 5.7% | -27.8% | 19.0% | 25.16% |
| 1 Yr | 9.6% | -27.8% | 18.5% | 20.13% |
| 3 Yr | 1.4%* | -28.3% | 7.9% | 23.03% |
| 5 Yr | 5.7%* | -11.6% | 11.4% | 42.95% |
| 10 Yr | 5.6%* | -0.5% | 12.6% | 69.91% |
* Annualized
Total Return Ranking - Calendar
| Period | FBTCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 9.9% | -12.6% | 19.0% | 17.61% |
| 2022 | -8.6% | -53.9% | 3.7% | 36.18% |
| 2021 | -4.3% | -33.9% | 26.0% | 86.18% |
| 2020 | 31.2% | -0.7% | 180.6% | 28.19% |
| 2019 | 24.8% | 4.6% | 63.8% | 59.40% |
NAV & Total Return History
FBTCX - Holdings
Concentration Analysis
| FBTCX | Category Low | Category High | FBTCX % Rank | |
|---|---|---|---|---|
| Net Assets | 1.78 B | 6.43 M | 45.7 B | 25.79% |
| Number of Holdings | 100 | 25 | 430 | 38.36% |
| Net Assets in Top 10 | 1.19 B | 2.55 M | 23.9 B | 26.42% |
| Weighting of Top 10 | 65.51% | 18.9% | 78.1% | 5.66% |
Top 10 Holdings
- ABBVIE INC 18.21%
- AMGEN INC 9.43%
- Fidelity Securities Lending Cash Central Fund 9.12%
- REGENERON PHARMACEUTICALS INC 7.01%
- VERTEX PHARMACEUTICALS INC 4.72%
- ALNYLAM PHARMACEUTICALS INC 4.53%
- ARGENX SE SPONSORED ADR 3.76%
- ASCENDIS PHARMA AS SPON ADR 3.50%
- VAXCYTE INC 2.61%
- CYTOKINETICS INC 2.60%
Asset Allocation
| Weighting | Return Low | Return High | FBTCX % Rank | |
|---|---|---|---|---|
| Stocks | 97.12% | 89.92% | 106.13% | 64.78% |
| Cash | 10.29% | 0.00% | 33.01% | 5.03% |
| Preferred Stocks | 1.80% | 0.00% | 7.86% | 13.21% |
| Bonds | 0.05% | 0.00% | 12.39% | 16.35% |
| Other | 0.00% | -22.99% | 23.24% | 71.07% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 53.25% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | FBTCX % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 59.26% | 100.00% | 25.97% |
| Utilities | 0.00% | 0.00% | 0.00% | 51.30% |
| Technology | 0.00% | 0.00% | 22.69% | 55.19% |
| Real Estate | 0.00% | 0.00% | 5.89% | 53.90% |
| Industrials | 0.00% | 0.00% | 7.02% | 55.19% |
| Financial Services | 0.00% | 0.00% | 1.60% | 65.58% |
| Energy | 0.00% | 0.00% | 0.00% | 51.30% |
| Communication Services | 0.00% | 0.00% | 9.11% | 51.95% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 57.79% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 53.90% |
| Basic Materials | 0.00% | 0.00% | 7.16% | 64.94% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | FBTCX % Rank | |
|---|---|---|---|---|
| US | 96.03% | 61.27% | 104.41% | 33.33% |
| Non US | 1.09% | 0.00% | 34.10% | 57.23% |
Bond Sector Breakdown
| Weighting | Return Low | Return High | FBTCX % Rank | |
|---|---|---|---|---|
| Cash & Equivalents | 10.29% | 0.00% | 100.00% | 8.81% |
| Derivative | 0.00% | -0.01% | 23.24% | 62.26% |
| Securitized | 0.00% | 0.00% | 0.00% | 50.72% |
| Corporate | 0.00% | 0.00% | 81.57% | 58.70% |
| Municipal | 0.00% | 0.00% | 0.00% | 50.72% |
| Government | 0.00% | 0.00% | 29.44% | 51.45% |
Bond Geographic Breakdown
| Weighting | Return Low | Return High | FBTCX % Rank | |
|---|---|---|---|---|
| US | 0.05% | 0.00% | 11.75% | 16.35% |
| Non US | 0.00% | 0.00% | 3.33% | 52.83% |
FBTCX - Expenses
Operational Fees
| FBTCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.71% | 0.08% | 4.48% | 24.53% |
| Management Fee | 0.70% | 0.03% | 1.25% | 54.72% |
| 12b-1 Fee | 1.00% | 0.00% | 1.00% | 90.91% |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| FBTCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | 1.00% | 1.00% | 1.00% | 65.00% |
Trading Fees
| FBTCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | 90.24% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| FBTCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 72.00% | 0.00% | 238.00% | 85.19% |
FBTCX - Distributions
Dividend Yield Analysis
| FBTCX | Category Low | Category High | FBTCX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 6.24% | 68.55% |
Dividend Distribution Analysis
| FBTCX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | None | Annual | Quarterly | Quarterly |
Net Income Ratio Analysis
| FBTCX | Category Low | Category High | FBTCX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.55% | -2.54% | 1.85% | 72.37% |
Capital Gain Distribution Analysis
| FBTCX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Semi-Annually | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 17, 2021 | $5.241 | OrdinaryDividend |
| Jul 09, 2021 | $0.006 | OrdinaryDividend |
| Dec 18, 2020 | $2.732 | OrdinaryDividend |
| Dec 20, 2019 | $1.849 | CapitalGainLongTerm |
| Dec 07, 2018 | $0.589 | CapitalGainLongTerm |
| Sep 14, 2015 | $0.235 | CapitalGainShortTerm |
| Sep 14, 2015 | $1.081 | CapitalGainLongTerm |
| Dec 15, 2014 | $0.420 | CapitalGainLongTerm |
| Sep 08, 2014 | $0.184 | CapitalGainLongTerm |
| Dec 16, 2013 | $0.052 | CapitalGainLongTerm |
| Sep 10, 2012 | $0.685 | CapitalGainLongTerm |
| Dec 17, 2007 | $0.170 | CapitalGainLongTerm |
| Sep 17, 2007 | $0.360 | CapitalGainLongTerm |
FBTCX - Fund Manager Analysis
Managers
Eirene Kontopoulos
Start Date
Tenure
Tenure Rank
Jul 15, 2018
3.88
3.9%
Eirene Kontopoulos joined Fidelity Investments in 2007, she has worked as a research analyst and portfolio manager.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 7.88 | 0.25 |